top of page
The Genetic Disease Company
GeneToBe's Mission
Preclinical and Clinical Stage Assets
Proof of concept in preclinical in vivo models
Technology
Next generation CRISPR/Cas9 platform (miCas9)
Create translational genetic disease models for demonstrating preclinical efficacy
Management
Team with over 150 years’ experience in drug discovery, development, registration, and commercialization that has produced multiple registered pharmaceutical products and candidates
bottom of page